Strides Pharma Profit Rises 81% To Rs 114 Crore In June Quarter
Revenue rose to Rs 1,120 crore for the June quarter against Rs 1,054 crore in the year-ago period, Strides Pharma Science said in a regulatory filing.
Strides Pharma Science on Tuesday said its profit increased 81% year-on-year to Rs 114 crore for the first quarter ended June 30, 2025. The company reported a profit after tax of Rs 63 crore for the April-June period of last year.
Revenue rose to Rs 1,120 crore for the June quarter against Rs 1,054 crore in the year-ago period, Strides Pharma Science said in a regulatory filing. "Our focus on cost management and diligent execution has enabled us to deliver robust results," Strides Pharma Science managing director and Group chief executive officer Badree Komandur said.
The company will enhance its research and development efforts during the year to drive sustainable long-term growth, he added.
Shares of Strides Pharma were trading 4.7% higher at Rs 965.95 apiece on the BSE.
